FEI ANNOUNCES DETECTION TIMES FOR MELOXICAM
Tuesday 07 June 2011
The FEI has announced detection times for Meloxicam (veterinary formulation known as Metacam®), a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in the equine athlete.
The detection time is the time taken for an active substance administered to a horse by a specified route and dosage to fall below a level that FEI-approved laboratories would declare a sample positive. It is important to note that detection times may vary depending on dose and number of injection sites used.
The findings of studies on the use of intravenously or orally administered Meloxicam show the urine and plasma (blood) detection time as 72 hours1.
This is the first COX-2 inhibitor on the FEI List of Detection Times, which contains common medications administered out of competition and is listed on the FEI Clean Sport website.
“We are committed to providing the tools to assist our athletes to adhere to the FEI’s Equine Anti-Doping Rules, and will add further medication detection times over the coming 12 months,” explains Graeme Cooke, Director of Veterinary Department at the FEI.
Meloxicam (Metacam®) is developed by Boehringer-Ingelheim.
1 Detection Time agreed with the European Horse Racing Scientific Liaison Committee (EHSLC)
| Recent Northern News | |
|---|---|
1daqxgvln99ql.jpg "Equine Influenza Update") |
Equine Influenza Update 21/05/2026 |
 |
Team Up - YOU can be part of it at South View and beyond! 13/05/2026 |
 |
Yorkshire Academy – Eggstraspecial Easter Activities! 10/04/2026 |
 |
Thrilling Competition at Holmside Hall for Penultimate Regional Academy Championships 25/03/2026 |
.jpg "Inaugural Regional Academy Show is Just around the Corner") |
Inaugural Regional Academy Show is Just around the Corner 10/03/2026 |